Literature DB >> 2013971

Pathophysiology and clinical basis of prevention and treatment of complications of chronic liver disease.

S Wagner1, H U Lautz, M J Müller, F W Schmidt.   

Abstract

Chronic liver failure is characterized by the appearance of jaundice, ascites, encephalopathy and/or gastrointestinal bleeding. Acute episodes of hepatic decompensation are frequently precipitated by additional events, e.g. septicaemia, diuretic therapy or excessive protein intake. Identification, correction and treatment of these precipitating factors are first steps in the management of chronic liver failure. Nutritional support is important in the treatment of cirrhotic patients, because malnutrition is one of the major determinants of patient outcome. Management of encephalopathy reduces the appearance of gut-derived nitrogenous toxins and corrects imbalances in amino acid metabolism. Treatment of ascites is salt restriction supported by gentle and incremental administration of diuretics. Ursodesoxycholic acid has become a new and promising modality in the management of cholestatic liver diseases. If conservative therapy fails to recompensate liver function, liver transplantation may be indicated.

Entities:  

Mesh:

Year:  1991        PMID: 2013971     DOI: 10.1007/bf01795954

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  76 in total

1.  The role of the kidney in Laennec's cirrhosis of the liver.

Authors:  S PAPPER
Journal:  Medicine (Baltimore)       Date:  1958-12       Impact factor: 1.889

Review 2.  Branched-chain amino acids in the management of hepatic encephalopathy: an analysis of variants.

Authors:  L S Eriksson; H O Conn
Journal:  Hepatology       Date:  1989-08       Impact factor: 17.425

3.  Lactulose detoxifies in vitro short-chain fatty acid production in colonic contents induced by blood: implications for hepatic coma.

Authors:  P B Mortensen; H S Rasmussen; K Holtug
Journal:  Gastroenterology       Date:  1988-03       Impact factor: 22.682

Review 4.  Glucose metabolism in cirrhosis: a review with some perspectives for the future.

Authors:  A S Petrides; R A DeFronzo
Journal:  Diabetes Metab Rev       Date:  1989-12

Review 5.  Parenteral nutrition in patients with liver disease.

Authors:  D B Silk
Journal:  J Hepatol       Date:  1988-10       Impact factor: 25.083

6.  Treatment of hepatic encephalopathy (HE) with the benzodiazepine antagonist flumazenil: a pilot study.

Authors:  R Meier; K Gyr
Journal:  Eur J Anaesthesiol Suppl       Date:  1988

7.  Carbohydrate and lipid metabolism in cirrhosis. Evidence that hepatic uptake of gluconeogenic precursors and of free fatty acids depends on effective hepatic flow.

Authors:  R Nosadini; A Avogaro; F Mollo; C Marescotti; A Tiengo; E Duner; C Merkel; A Gatta; R Zuin; S de Kreutzenberg
Journal:  J Clin Endocrinol Metab       Date:  1984-06       Impact factor: 5.958

8.  Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?

Authors:  R Poupon; Y Chrétien; R E Poupon; F Ballet; Y Calmus; F Darnis
Journal:  Lancet       Date:  1987-04-11       Impact factor: 79.321

9.  Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study.

Authors:  P Ginés; V Arroyo; E Quintero; R Planas; F Bory; J Cabrera; A Rimola; J Viver; J Camps; W Jiménez
Journal:  Gastroenterology       Date:  1987-08       Impact factor: 22.682

10.  Transmethylation, transsulfuration, and aminopropylation reactions of S-adenosyl-L-methionine in vivo.

Authors:  P Giulidori; M Galli-Kienle; E Catto; G Stramentinoli
Journal:  J Biol Chem       Date:  1984-04-10       Impact factor: 5.157

View more
  1 in total

1.  Protein-calorie malnutrition in liver cirrhosis.

Authors:  H U Lautz; O Selberg; J Körber; M Bürger; M J Müller
Journal:  Clin Investig       Date:  1992-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.